Altai Protocol Library New Protocol: Neoadjuvant Low-dose Pembrolizumab for Triple-Negative Breast Cancer U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Reference: Adjuvant Nivolumab for Muscle-Invasive Bladder Cancer U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Protocol: Adjuvant Nivolumab with CISplatin Concurrently with Radiotherapy for Head and Neck Cancer U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Reference: FOLFOXIRI with Panitumumab for 1st Line Metastatic RAS/RAF WT Colorectal Cancer U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Reference: Erdafitinib for Cisplatin-Ineligible FGFR-Altered Metastatic Urothelial Carcinoma U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Reference: Datopotamab for HR-Positive HER2-Negative Metastatic Breast Cancer U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Reference: Carboplatin with EC->T for Early-Stage Triple-Negative Breast Cancer U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Protocol: Cabozantinib + Temozolomide for Leiomyosarcoma U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Drug: SubQ Amivantamab with Lazertinib for EGFR-Mutated NSCLC U. Darda Bayraktar, MD 2026-01-18
Altai Protocol Library New Reference: Niraparib – Abiraterone for HRR-Deficient Metastatic Castration-Sensitive Prostate Cancer U. Darda Bayraktar, MD 2025-12-19
